// App-Quantinova.ai

TCT-444 : One-Year Prognostic Utility of the SYNTAX Score II in Complex PCI with Biodegradable Polymer Drug-Eluting Stents: A PANDA III Analysis

Researchers

Presenter

  • Changdong Guan

Principal Investigators

  • Bo Xu

  • Runlin Gao

  • Gregg Stone

Medical Centers

  • Columbia University Medical Center/NewYork-Presbyterian Hospital, New York, New York, United States

  • Fu Wai Hospital, National Center for Cardiovascular Diseases, China, Beijing, China

  • Fu Wai Hospital, Beijing, Beijing, China

Locations

  • United States

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

Biomarkers

  • PANDAR

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved